JW Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20,552	39,233	10,430	15,909	33,898	33,366
Short-Term Investments	11,133	10,108	22,121	48,288	53,781	32,300
Trading Asset Securities	34,634	12,000	-	30,000	62,000	-
Cash & Short-Term Investments	66,319	61,341	32,551	94,196	149,678	65,666
Cash Growth	21.86%	88.45%	-65.44%	-37.07%	127.94%	18.76%
Accounts Receivable	115,158	114,573	135,503	159,378	147,523	151,780
Other Receivables	-	3,581	3,571	5,644	5,962	5,499
Receivables	115,158	118,154	155,763	173,521	156,362	187,379
Inventory	114,739	109,897	111,733	106,091	111,668	102,528
Prepaid Expenses	-	2,216	1,883	1,848	1,774	5,152
Other Current Assets	12,680	4,904	4,484	2,434	5,975	5,727
Total Current Assets	308,895	296,512	306,413	378,091	425,457	366,452
Property, Plant & Equipment	162,410	165,279	172,291	155,724	123,048	118,392
Long-Term Investments	64,203	33,240	63,801	36,995	33,957	98,884
Goodwill	-	-	-	1,404	-	-
Other Intangible Assets	12,572	12,877	10,878	12,248	11,750	12,773
Long-Term Deferred Tax Assets	16,701	20,363	13,569	20,623	21,811	20,802
Long-Term Deferred Charges	54,014	51,581	29,958	16,704	4,516	8,700
Other Long-Term Assets	2,812	9,144	7,688	7,746	269.55	4,050
Total Assets	621,608	605,273	604,599	645,039	627,973	633,053
Accounts Payable	-	55,864	59,613	73,847	82,908	51,643
Accrued Expenses	-	32,842	22,204	14,495	12,472	10,343
Short-Term Debt	20,000	20,000	31,400	72,968	46,000	81,823
Current Portion of Long-Term Debt	12,102	12,102	10,000	40,166	160,440	39,977
Current Portion of Leases	4,052	4,079	4,352	4,270	1,253	1,274
Current Income Taxes Payable	12,379	12,964	7,794	11,114	10,153	24,877
Current Unearned Revenue	-	174.55	159.58	159.58	153.65	551.41
Other Current Liabilities	162,820	71,133	73,092	69,907	66,752	72,188
Total Current Liabilities	211,353	209,159	208,615	286,927	380,131	282,678
Long-Term Debt	-	-	25,102	30,000	-	120,744
Long-Term Leases	17,971	18,454	20,872	22,876	1,849	1,326
Long-Term Unearned Revenue	-	997.4	1,157	1,317	-	-
Pension & Post-Retirement Benefits	2,964	1,080	5,892	10,321	7,314	22,402
Long-Term Deferred Tax Liabilities	1,465	1,106	1,166	1,276	1,399	-
Other Long-Term Liabilities	6,075	5,108	12,309	26,882	11,520	17,364
Total Liabilities	239,829	235,904	275,112	379,598	402,214	444,514
Common Stock	62,253	62,253	62,253	61,100	59,418	57,202
Additional Paid-In Capital	68,321	68,321	68,321	69,475	71,063	63,334
Retained Earnings	226,342	214,569	164,123	113,029	89,130	58,595
Treasury Stock	-21,616	-21,616	-12,076	-11,325	-11,065	-10,783
Comprehensive Income & Other	46,478	45,842	46,865	33,162	31,808	32,847
Total Common Equity	381,779	369,370	329,487	265,440	240,354	201,195
Minority Interest	0	0	0	0	-14,595	-12,655
Shareholders' Equity	381,779	369,370	329,487	265,440	225,759	188,540
Total Liabilities & Equity	621,608	605,273	604,599	645,039	627,973	633,053
Total Debt	54,125	54,635	91,726	170,280	209,542	245,145
Net Cash (Debt)	12,194	6,706	-59,175	-76,084	-59,864	-179,479
Net Cash Per Share	540.04	295.95	-2405.58	-3196.37	-2577.51	-7733.47
Filing Date Shares Outstanding	24.15	22.55	22.97	22.54	22.34	22.35
Total Common Shares Outstanding	24.15	22.55	23.31	23.33	23.34	23.21
Working Capital	97,542	87,353	97,798	91,164	45,326	83,774
Book Value Per Share	15808.24	16380.38	14136.82	11375.92	10299.98	8669.19
Tangible Book Value	369,207	356,493	318,608	251,788	228,604	188,422
Tangible Book Value Per Share	15287.68	15809.34	13670.08	10790.83	9796.44	8118.81
Land	44,536	44,536	44,536	26,555	22,178	22,178
Buildings	67,980	120,753	120,046	112,052	110,929	110,161
Machinery	23,330	163,999	173,804	169,111	158,179	151,192
Construction In Progress	3,029	3,128	3,588	6,064	8,128	849.45